Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

dc.contributor.authorAlonso Menchén, David
dc.contributor.authorSánchez Carrillo, Carlos
dc.contributor.authorAlcalá Hernández, Luis
dc.contributor.authorSoriano Martín, Ana
dc.contributor.authorCercenado Mansilla, Emilia
dc.contributor.authorBurillo Albizua, Almudena
dc.contributor.authorSerrano Lobo, Julia
dc.contributor.authorPérez Latorre, Leire
dc.contributor.authorMuñoz García, Patricia Carmen
dc.contributor.authorBouza Santiago, Emilio
dc.date.accessioned2026-01-14T11:29:37Z
dc.date.available2026-01-14T11:29:37Z
dc.date.issued2024-02-26
dc.descriptionFinanciado con Fondos FEDER
dc.description.abstractEste estudio analiza la evolución de la incidencia, etiología y carga asistencial de las infecciones del torrente sanguíneo (BSI) en un hospital terciario durante un período de 12 años (2010–2021), incluyendo el impacto de la pandemia de COVID-19. Se evaluaron todos los hemocultivos bacterianos y fúngicos procesados en el laboratorio, identificándose 17 938 episodios significativos de bacteriemia o fungemia. La incidencia global de BSI por 1 000 ingresos se mantuvo estable (media 31,1), mientras que las tasas poblacionales mostraron una tendencia descendente. Los bacilos gramnegativos se consolidaron como la etiología más frecuente, con Escherichia coli como principal patógeno, sin un aumento significativo de fenotipos de resistencia como BLEE o carbapenemasas. Se observó un descenso de los episodios por Staphylococcus aureus resistente a meticilina. En 2020 se detectó un aumento transitorio de BSI, especialmente de origen relacionado con catéteres y candidemias, atribuible al impacto asistencial de la pandemia. Los autores concluyen que no se ha producido un incremento sostenido de la incidencia de BSI, pero destacan la necesidad de mantener programas de vigilancia y control de infecciones.
dc.description.abstractIntroduction: The epidemiological evolution of bloodstream infections (BSIs) in the last decade is not clearly defined. Our aim was to analyze the changes in the workload in our institution and to describe the evolution of the incidence and etiology of BSIs in a 12-year period, including the COVID-19 pandemic. Methods: All blood cultures received in the laboratory of a tertiary general hospital between 2010 and 2021 were analyzed. Bloodstream infection episodes refer to each episode of bacteremia or fungemia in each patient. Incidence rates per 1000 admissions and per 100,000 population were calculated. Results: No significant changes in the incidence of BSI episodes/1000 admissions were observed (mean, 31.1), while estimated population-based incidences showed declining trends (mean, 182.8/100,000 inhabitants). There was a slight increase in BSI episodes per 1000 admissions caused by Gram-negatives (mean, 16.6/1000 admissions) and E. coli was the most frequent pathogen (mean, 8.5/1000 admissions). There was no significant rise in episodes caused by ESBL- and carbapenemase-producing E. coli or K. pneumoniae, with a decline in those caused by methicillin-resistant S. aureus. A spike in BSI episodes, fungal BSIs and catheter-related infections was detected in 2020, during the COVID-19 outbreak. Conclusions: No clear increase in the incidence of BSI episodes was detected in our center over this period. Gram-negatives are the most frequent etiology, with no clear rise in antimicrobial resistance phenotypes. The COVID-19 pandemic accounted for a small increase in BSI episodes in 2020, probably related to the increase of catheter-related infections.
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipInstituto de Salud Carlos III (España)
dc.description.statuspub
dc.identifier.citationAlonso-Menchén D, Sánchez-Carrillo C, Alcalá L, Soriano-Martín A, Cercenado E, Burillo A, Serrano-Lobo J, Pérez-Latorre L, Muñoz P, Bouza E. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010-2021). Infect Dis (Lond). 2024 Jun;56(6):441-450. doi: 10.1080/23744235.2024.2320333
dc.identifier.doi10.1080/23744235.2024.2320333
dc.identifier.issn2374-4235
dc.identifier.issn2374-4243
dc.identifier.officialurlhttps://doi.org/10.1080/23744235.2024.2320333
dc.identifier.pmid38407125
dc.identifier.relatedurlhttps://www.tandfonline.com/doi/10.1080/23744235.2024.2320333?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.identifier.relatedurlhttps://pubmed.ncbi.nlm.nih.gov/38407125/
dc.identifier.urihttps://hdl.handle.net/20.500.14352/130173
dc.issue.number6
dc.journal.titleInfectious Diseases
dc.language.isoeng
dc.publisherTaylor & Francis
dc.relation.projectIDPI20/00575
dc.relation.projectIDPI20/01201
dc.rights.accessRightsrestricted access
dc.subject.cdu579.26
dc.subject.keywordBloodstream infection
dc.subject.keywordBacteremia
dc.subject.keywordIncidence
dc.subject.keywordCatheter-related bacteremia
dc.subject.keywordAntimicrobial resistance
dc.subject.ucmMedicina
dc.subject.unesco32 Ciencias Médicas
dc.titleBloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number56
dspace.entity.typePublication
relation.isAuthorOfPublication533334d8-3141-4a95-be6d-aeec09717d3a
relation.isAuthorOfPublicationa8159575-3720-4c21-a081-cc3fb70652d4
relation.isAuthorOfPublication057f539e-41b0-4a1e-b97b-204a23ead398
relation.isAuthorOfPublication617e0427-008c-4911-8a51-5c307739f9cf
relation.isAuthorOfPublication.latestForDiscovery533334d8-3141-4a95-be6d-aeec09717d3a

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bloodstream infections trends and evolution ID feb 2024.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format

Collections